Letter from the Editor

Publikation: Bidrag til tidsskrift › Leder › Forskning

Standard

Letter from the Editor. / Pedersen, Anders Elm.

I: Immunopharmacology and Immunotoxicology, Bind 39, Nr. 1, 02.2017, s. 1.

Publikation: Bidrag til tidsskrift › Leder › Forskning

Harvard

Pedersen, AE 2017, 'Letter from the Editor', Immunopharmacology and Immunotoxicology, bind 39, nr. 1, s. 1. https://doi.org/10.1080/08923973.2017.1264166

APA

Pedersen, A. E. (2017). Letter from the Editor. Immunopharmacology and Immunotoxicology, 39(1), 1. https://doi.org/10.1080/08923973.2017.1264166

Vancouver

Pedersen AE. Letter from the Editor. Immunopharmacology and Immunotoxicology. 2017 feb.;39(1):1. https://doi.org/10.1080/08923973.2017.1264166

Author

Pedersen, Anders Elm. / Letter from the Editor. I: Immunopharmacology and Immunotoxicology. 2017 ; Bind 39, Nr. 1. s. 1.

Bibtex

@article{7fcf9b6182c9448ea6623f7fdfe73a30,
title = "Letter from the Editor",
keywords = "Antibodies, Clinical Trials as Topic, Humans, Immunotherapy, Periodicals as Topic",
author = "Pedersen, {Anders Elm}",
year = "2017",
month = feb,
doi = "10.1080/08923973.2017.1264166",
language = "English",
volume = "39",
pages = "1",
journal = "Immunopharmacology and Immunotoxicology",
issn = "0892-3973",
publisher = "Taylor & Francis",
number = "1",

}

RIS

TY - JOUR

T1 - Letter from the Editor

AU - Pedersen, Anders Elm

PY - 2017/2

Y1 - 2017/2

KW - Antibodies

KW - Clinical Trials as Topic

KW - Humans

KW - Immunotherapy

KW - Periodicals as Topic

U2 - 10.1080/08923973.2017.1264166

DO - 10.1080/08923973.2017.1264166

M3 - Editorial

C2 - 28071184

VL - 39

SP - 1

JO - Immunopharmacology and Immunotoxicology

JF - Immunopharmacology and Immunotoxicology

SN - 0892-3973

IS - 1

ER -

ID: 179462537